GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO
GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO
Price:
2 640
INR
1.66%
Market Closed
Market Cap:
₹447.2B
Cash Flow Statement
Cash Flow Statement
GlaxoSmithKline Pharmaceuticals Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Currency: INR
| Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
6 473
|
6 251
|
7 231
|
8 213
|
7 675
|
7 553
|
8 374
|
8 739
|
9 598
|
10 855
|
12 552
|
12 970
|
|
| Depreciation & Amortization |
827
|
0
|
793
|
0
|
682
|
0
|
658
|
0
|
697
|
0
|
668
|
997
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
82
|
0
|
|
| Other Non-Cash Items |
(976)
|
0
|
(1 233)
|
0
|
(243)
|
0
|
(1 085)
|
(1 085)
|
(2 543)
|
(6 716)
|
(1 352)
|
2 138
|
|
| Cash Taxes Paid |
1 859
|
0
|
1 470
|
0
|
1 205
|
0
|
2 647
|
0
|
2 542
|
0
|
817
|
1 879
|
|
| Cash Interest Paid |
41
|
0
|
35
|
0
|
20
|
0
|
14
|
0
|
18
|
0
|
13
|
25
|
|
| Change in Working Capital |
(1 418)
|
(682)
|
(1 012)
|
580
|
(6)
|
(3 860)
|
(3 105)
|
(1 422)
|
(1 932)
|
4 877
|
1 031
|
(8 673)
|
|
| Cash from Operating Activities |
4 905
N/A
|
5 419
+10%
|
5 779
+7%
|
8 354
+45%
|
8 108
-3%
|
4 133
-49%
|
4 842
+17%
|
6 890
+42%
|
5 820
-16%
|
9 713
+67%
|
12 899
+33%
|
7 433
-42%
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
(1 584)
|
0
|
(442)
|
0
|
(346)
|
0
|
(440)
|
0
|
(312)
|
0
|
(247)
|
(418)
|
|
| Other Items |
1 015
|
3 402
|
4 628
|
1 852
|
(3 709)
|
6 237
|
8 519
|
(694)
|
399
|
(3 996)
|
(211)
|
5 282
|
|
| Cash from Investing Activities |
(568)
N/A
|
1 819
N/A
|
4 186
+130%
|
1 410
-66%
|
(4 055)
N/A
|
5 890
N/A
|
8 079
+37%
|
(1 135)
N/A
|
87
N/A
|
(4 308)
N/A
|
(458)
+89%
|
4 864
N/A
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Debt |
(151)
|
0
|
(150)
|
0
|
(156)
|
0
|
(169)
|
0
|
(181)
|
0
|
(187)
|
(267)
|
|
| Cash Paid for Dividends |
(3 388)
|
0
|
(6 776)
|
0
|
(5 066)
|
0
|
(15 255)
|
0
|
(5 416)
|
0
|
(7 494)
|
(14 634)
|
|
| Other |
(738)
|
(3 427)
|
(35)
|
1 664
|
(20)
|
(10 207)
|
(10)
|
9 851
|
(18)
|
(54)
|
(13)
|
5 511
|
|
| Cash from Financing Activities |
(4 276)
N/A
|
(6 965)
-63%
|
(6 961)
+0%
|
(5 262)
+24%
|
(5 242)
+0%
|
(15 429)
-194%
|
(15 433)
0%
|
(5 573)
+64%
|
(5 615)
-1%
|
(5 651)
-1%
|
(7 694)
-36%
|
(9 390)
-22%
|
|
| Change in Cash | |||||||||||||
| Net Change in Cash |
60
N/A
|
272
+351%
|
3 004
+1 003%
|
4 502
+50%
|
(1 190)
N/A
|
(5 406)
-354%
|
(2 512)
+54%
|
182
N/A
|
292
+61%
|
(246)
N/A
|
4 747
N/A
|
2 907
-39%
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
3 321
N/A
|
5 419
+63%
|
5 337
-2%
|
8 354
+57%
|
7 761
-7%
|
4 133
-47%
|
4 402
+7%
|
6 890
+57%
|
5 508
-20%
|
9 713
+76%
|
12 652
+30%
|
7 015
-45%
|
|
Switch to:
Switch to:
See Also
Discover More
